News & SEC Filings
News
21 September 2020Regulatory
Intended Delisting and Cancellation of Ordinary Shares from Trading on AIM
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014 (“MAR”). UPON PUBLICATION OF THIS ANNOUNCEMENT THIS INFORMATION IS NOW CONSIDERED IN THE PUBLIC DOMAIN. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN
17 September 2020Company News, Regulatory
Verona Pharma to Ring the Nasdaq Closing Bell to celebrate $200 million financing
LONDON and RALEIGH, N.C., Sept. 17, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that David Zaccardelli, Pharm. D., President and CEO of Verona Pharma, will ring the
16 September 2020Regulatory
Verona Pharma Announces Publication of Phase 2b COPD Symptom Data in the International Journal of Chronic Obstructive Pulmonary Disease
Publication highlights ensifentrine’s potential to provide rapid symptom relief LONDON and RALEIGH, N.C., Sept. 16, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces
8 September 2020Regulatory
Verona Pharma Initiates Pilot Study with pMDI Ensifentrine in U.S. Patients Hospitalized with COVID-19
LONDON and RALEIGH, N.C., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces the initiation of a pilot study to investigate the efficacy and safety of ensifentrine delivered via pressurized metered-dose inhaler (“pMDI”) formulation in U.S. patients hospitalized with COVID-19.
2 September 2020Regulatory
Verona Pharma to Present at H.C. Wainwright 22nd Annual Global Virtual Investment Conference
LONDON and RALEIGH, N.C., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that David Zaccardelli, Chief Executive Officer and President, will present a company
SEC Filings
| Date | Description | Form | Filing Group | View |
|---|---|---|---|---|
| 14 Sep 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 27 Aug 2020 | EFFECT | EFFECT | Other | |
| 27 Aug 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 25 Aug 2020 | This filing is a pre-effective amendment to an F-1 filing | F-1/A | Registration Statements | |
| 25 Aug 2020 | Amendment to a previously filed 6-K | 6-K/A | Current Reports | |
| 20 Aug 2020 | Securities offered to employees pursuant to employee benefit plans | S-8 | Registration Statements | |
| 19 Aug 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 17 Aug 2020 | Registration statement for certain foreign private issuers | F-1 | Registration Statements | |
| 14 Aug 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 10 Aug 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 03 Aug 2020 | An amendment to a SC 13D filing | SC 13D/A | Other | |
| 31 Jul 2020 | An amendment to a SC 13D filing | SC 13D/A | Other | |
| 30 Jul 2020 | - | D | Other | |
| 24 Jul 2020 | An amendment to the SC 13G filing | SC 13G/A | Other | |
| 24 Jul 2020 | A statement of beneficial ownership of common stock by certain persons | SC 13G | Other | |
| 22 Jul 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 20 Jul 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 16 Jul 2020 | Amendment to a previously filed 20-F | 20-F/A | Annual Filings | |
| 14 May 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 30 Apr 2020 | Securities offered to employees pursuant to employee benefit plans | S-8 | Registration Statements | |
| 30 Apr 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 16 Apr 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 14 Apr 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 06 Apr 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 30 Mar 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 10 Mar 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 27 Feb 2020 | Registration of securities of foreign private issuers pursuant to section 12(b) or (g) | 20-F | Annual Filings | |
| 05 Feb 2020 | An amendment to the SC 13G filing | SC 13G/A | Other | |
| 04 Feb 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 17 Jan 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 29 Nov 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 22 Nov 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 22 Nov 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 05 Nov 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 19 Sep 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 14 Aug 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 08 Aug 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 07 Aug 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 05 Jun 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 14 May 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 07 May 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 03 May 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 12 Apr 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 02 Apr 2019 | Filing by person(s) reporting owned shares of common stock in a public company >5% | SC 13D | Other | |
| 26 Mar 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 26 Mar 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 19 Mar 2019 | Registration of securities of foreign private issuers pursuant to section 12(b) or (g) | 20-F | Annual Filings | |
| 12 Mar 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 28 Feb 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 12 Feb 2019 | An amendment to the SC 13G filing | SC 13G/A | Other | |
| 11 Feb 2019 | An amendment to the SC 13G filing | SC 13G/A | Other | |
| 04 Jan 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 06 Nov 2018 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 25 Sep 2018 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 14 Aug 2018 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 07 Aug 2018 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 28 Jun 2018 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 04 Jun 2018 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 01 Jun 2018 | EFFECT | EFFECT | Other | |
| 22 May 2018 | Registration statement for certain foreign private issuers offered for certain transactions | F-3 | Registration Statements | |
| 08 May 2018 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 04 May 2018 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 04 May 2018 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 18 Apr 2018 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 29 Mar 2018 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 22 Mar 2018 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 27 Feb 2018 | Annual Report of foreign issuer rules 13 and 15(d) of the Securities Exchange Act | 20-F | Annual Filings | |
| 13 Feb 2018 | An amendment to the SC 13G filing | SC 13G/A | Other | |
| 06 Feb 2018 | An amendment to the SC 13G filing | SC 13G/A | Other | |
| 26 Jan 2018 | An amendment to a SC 13D filing | SC 13D/A | Other | |
| 09 Nov 2017 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 21 Sep 2017 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 12 Sep 2017 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 24 Aug 2017 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 08 Aug 2017 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 26 May 2017 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 18 May 2017 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 12 May 2017 | A statement of beneficial ownership of common stock by certain persons | SC 13G | Other | |
| 09 May 2017 | Filing by person(s) reporting owned shares of common stock in a public company >5% | SC 13D | Other | |
| 09 May 2017 | A statement of beneficial ownership of common stock by certain persons | SC 13G | Other | |
| 08 May 2017 | A statement of beneficial ownership of common stock by certain persons | SC 13G | Other | |
| 08 May 2017 | Filing by person(s) reporting owned shares of common stock in a public company >5% | SC 13D | Other | |
| 08 May 2017 | Filing by person(s) reporting owned shares of common stock in a public company >5% | SC 13D | Other | |
| 05 May 2017 | A statement of beneficial ownership of common stock by certain persons | SC 13G | Other | |
| 05 May 2017 | A statement of beneficial ownership of common stock by certain persons | SC 13G | Other | |
| 03 May 2017 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 01 May 2017 | CT ORDER | CT ORDER | Other | |
| 28 Apr 2017 | Securities offered to employees pursuant to employee benefit plans | S-8 | Registration Statements | |
| 28 Apr 2017 | Form of prospectus disclosing information facts events covered in both forms 424B1 424B3 | 424B4 | Registration Statements | |
| 26 Apr 2017 | Registration of up to an additional 20% of securities for an offering filed on an F-1 | F-1MEF | Registration Statements | |
| 26 Apr 2017 | This filing is a pre-effective amendment to an F-1 filing | F-1/A | Registration Statements | |
| 26 Apr 2017 | EFFECT | EFFECT | Other | |
| 26 Apr 2017 | EFFECT | EFFECT | Other | |
| 21 Apr 2017 | CERTNAS | CERTNAS | Other | |
| 19 Apr 2017 | Registration of certain classes of securities 12(b) of the Securities Exchange Act | 8-A12B | Registration Statements | |
| 19 Apr 2017 | CERTNAS | CERTNAS | Other | |
| 18 Apr 2017 | This filing is a pre-effective amendment to an F-1 filing | F-1/A | Registration Statements | |
| 18 Apr 2017 | Registration of depository shares evidenced by American Depository Receipts | F-6 | Registration Statements | |
| 03 Apr 2017 | Registration statement for certain foreign private issuers | F-1 | Registration Statements | |
| 13 Feb 2017 | A statement of beneficial ownership of common stock by certain persons | SC 13G | Other | |
| 20 Jul 2016 | - | D | Other |
Verona Pharma
Investor Information
© Verona Pharma plc 2020. All rights reserved